New Orleans - Oral bexarotene (Targretin) appears to be a good palliative treatment for patients with recalcitrant late-stage S?zary syndrome, but
Recent Povorcitinib 2b Study Shows Improved Repigmentation
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Investigational LEO Pharma IL-22 Receptor Improves EASI Scores in AD
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
POLL: What Topics Did You Most Enjoy at AAD 2023?
Lanolin Named Allergen of the Year